Pfizer ends late-stage lung-cancer study - Reuters

Pfizer ends late-stage lung-cancer study
Reuters
Pfizer shares were down 4 cents at 18.52 in after hours trading. They earlier closed down 7 cents at $18.56 on the New York Stock Exchange. ...